Emcure Pharmaceuticals Ltd (EMCURE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 10039308, "name": "Emcure Pharma", "stock_name": "Emcure Pharma", "full_name": "Emcure Pharmaceuticals Ltd", "name_url": "stocks-analysis/emcure-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,975.55", "chg": -25.25, "chgp": "-1.26%", "dir": -1, "prev_price": "2,000.80", "mcapval": "37,986.00 Cr", "mcap": "Small Cap", "scripcode": 544210, "symbol": "EMCURE", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE168P01015", "curr_date": "Sep 22, 03:30 PM", "curr_time": "17:33 PM", "last_traded_at": "Sep 22, 03:30 PM IST", "bse_nse_vol": "49.73 k", "exc_status": "Active", "traded_date": "Sep 22, 2026", "traded_date_str": "2026 09 22", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/emcure-pharma-10039308-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Emcure Pharmaceuticals Upgraded to Buy on Strong Financials and Bullish Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/emcure-pharmaceuticals-upgraded-to-buy-on-strong-financials-and-bullish-technicals-4199259", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/EmcurePharmaceu_mojoScore_4199259.png", "date": "2026-09-21 08:18:47", "description": "Emcure Pharmaceuticals Ltd has seen its investment rating upgraded from Hold to Buy, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, announced on 18 September 2026, follows a robust quarter and sustained market-beating returns, positioning the small-cap pharmaceutical firm favourably amid a challenging sector backdrop." }, { "title": "Emcure Pharmaceuticals Ltd Sees Bullish Momentum Shift Amid Strong Technical Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-sees-bullish-momentum-shift-amid-strong-technical-signals-4199189", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/EmcurePharmaceu_technicaldot_4199189.png", "date": "2026-09-21 08:04:28", "description": "Emcure Pharmaceuticals Ltd has demonstrated a significant shift in price momentum, supported by a series of technical indicator upgrades that suggest a strengthening bullish trend. The stock’s recent surge to ₹2,101.00, hitting its 52-week high, alongside an upgraded MarketsMOJO Mojo Grade from Hold to Buy, signals renewed investor confidence in this small-cap pharmaceutical player." }, { "title": "Emcure Pharmaceuticals Ltd is Rated Buy by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/emcure-pharmaceuticals-ltd-is-rated-buy-by-marketsmojo-4197950", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/EmcurePharmaceu_mojoScore_4197950.png", "date": "2026-09-19 10:10:20", "description": "Emcure Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 18 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 September 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Emcure Pharmaceuticals Gains 1.97%: 3 Key Factors Driving the Surge", "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-gains-197-3-key-factors-driving-the-surge-4197795", "imagepath": "", "date": "2026-09-19 10:01:11", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>15 Sep:</strong> Stock opens at Rs.1,994.15, up 0.88% while Sensex falls 1.69%</p>\n <p><strong>16 Sep:</strong> Sharp decline of 3.10% to Rs.1,932.25 amid sector volatility</p>\n <p><strong>17 Sep:</strong> Continued dip of 1.15% to Rs.1,910.10 on lower volume</p>\n <p><strong>18 Sep:</strong> Strong surge of 5.53% to Rs.2,015.75, hitting new 52-week and all-time highs</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,976.75</div></div>\n <div class=\"stat-item\"><div class=\"stat-labe..." }, { "title": "Broad-Based Technical Strength Lifts Emcure Pharmaceuticals Ltd to 52-Week High of Rs 2101", "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-hits-new-52-week-high-at-rs2101-4197702", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/EmcurePharmaceu_priceRelatedfactors_4197702.png", "date": "2026-09-18 15:38:42", "description": "Surging past its previous peaks, Emcure Pharmaceuticals Ltd touched a new 52-week high of Rs 2101 on 18 Sep 2026, marking a remarkable 53.5% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and a market environment where the Sensex trades near its 52-week low, underscoring the stock’s standout performance in the Pharmaceuticals & Biotechnology sector." }, { "title": "Emcure Pharmaceuticals Ltd Surges 9.94% to Day's High of Rs 2101 — Outperforms Sector by 9.3 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-hits-intraday-high-with-994-surge-on-18-sep-2026-4197689", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/EmcurePharmaceu_priceRelatedfactors_4197689.png", "date": "2026-09-18 15:37:56", "description": "The Sensex edged lower by 0.03% on 18 Sep 2026, while Emcure Pharmaceuticals Ltd surged 9.94%, hitting a fresh 52-week and all-time high of Rs 2101. This 9.3-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a market-wide lift." }, { "title": "Strong Momentum Meets Stretched Valuations as Emcure Pharmaceuticals Ltd Reaches All-Time High", "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-hits-all-time-high-amid-strong-financial-performance-4197672", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/EmcurePharmaceu_priceRelatedfactors_4197672.png", "date": "2026-09-18 15:24:36", "description": "" }, { "title": "Emcure Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/emcure-pharmaceuticals-ltd-is-rated-hold-4186350", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/EmcurePharmaceu_mojoScore_4186350.png", "date": "2026-09-08 10:10:51", "description": "Emcure Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 24 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Emcure Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/emcure-pharmaceuticals-ltd-is-rated-hold-4171438", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/EmcurePharmaceu_mojoScore_4171438.png", "date": "2026-08-27 10:10:43", "description": "Emcure Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 24 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 August 2026, providing investors with the most up-to-date view of the company’s performance and outlook." } ], "total": 463, "sid": "10039308", "stock_news_url": "https://www.marketsmojo.com/news/emcure-pharmaceuticals-10039308" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS", "datetime": "11-Sep-2026", "details": "Allotment of 11400 Equity Shares pursuant to exercise of ESOPs under Emcure - Employee Stock Option Scheme 2013", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Credit Rating", "datetime": "01-Sep-2026", "details": "Reaffirmation of Credit Ratings by CARE Ratings Limited", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "01-Sep-2026", "details": "Intimation of schedule of Investor Meet on Friday September 04 2026", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Emcure Pharmaceuticals Ltd has declared <strong>36%</strong> dividend, ex-date: 04 Sep 26", "dt": "2026-09-04", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

15 Sep: Stock opens at Rs.1,994.15, up 0.88% while Sensex falls 1.69%

16 Sep: Sharp decline of 3.10% to Rs.1,932.25 amid sector volatility

17 Sep: Continued dip of 1.15% to Rs.1,910.10 on lower volume

18 Sep: Strong surge of 5.53% to Rs.2,015.75, hitting new 52-week and all-time highs

Week Open

Rs.1,976.75

Read full news article

Broad-Based Technical Strength Lifts Emcure Pharmaceuticals Ltd to 52-Week High of Rs 2101

2026-09-18 15:38:42

Surging past its previous peaks, Emcure Pharmaceuticals Ltd touched a new 52-week high of Rs 2101 on 18 Sep 2026, marking a remarkable 53.5% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and a market environment where the Sensex trades near its 52-week low, underscoring the stock’s standout performance in the Pharmaceuticals & Biotechnology sector.

Read full news article

Emcure Pharmaceuticals Ltd Surges 9.94% to Day's High of Rs 2101 — Outperforms Sector by 9.3 Percentage Points

2026-09-18 15:37:56

The Sensex edged lower by 0.03% on 18 Sep 2026, while Emcure Pharmaceuticals Ltd surged 9.94%, hitting a fresh 52-week and all-time high of Rs 2101. This 9.3-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a market-wide lift.

Read full news article

Strong Momentum Meets Stretched Valuations as Emcure Pharmaceuticals Ltd Reaches All-Time High

2026-09-18 15:24:36

Read full news article

Emcure Pharmaceuticals Ltd is Rated Hold

2026-09-08 10:10:51

Emcure Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 24 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Emcure Pharmaceuticals Ltd is Rated Hold

2026-08-27 10:10:43

Emcure Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 24 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 August 2026, providing investors with the most up-to-date view of the company’s performance and outlook.

Read full news article